Cargando…
Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets
PURPOSE: It is projected that approximately 50,000 new cases of prostate cancer will be diagnosed in 2020 in India. Survival has improved because of the development of effective drugs such as abiraterone acetate, but universal accessibility to treatment is not always possible because of cost constra...
Autores principales: | Patel, Amol, Tannock, Ian F., Srivastava, Priyanka, Biswas, Bivas, Gupta, Vineet Govinda, Batra, Atul, Bhethanabhotla, Sainath, Pramanik, Raja, Mahindru, Shubh, Tilak, TVSVGK, Das, Chandan Krishna, Mehta, Prashant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113122/ https://www.ncbi.nlm.nih.gov/pubmed/32125899 http://dx.doi.org/10.1200/JGO.19.00341 |
Ejemplares similares
-
Oncotype DX: Where Does It Stand in India?
por: Batra, Atul, et al.
Publicado: (2019) -
Revisiting Fulvestrant Dosing in Uncertain Economic Times
por: Patel, Amol, et al.
Publicado: (2021) -
Reply to D. O'Reilly et al
por: Patel, Amol, et al.
Publicado: (2021) -
Craniovertebral Junction Instability: A Review of Facts about Facets
por: Goel, Atul
Publicado: (2015) -
Real-World Breast Cancer Patient Follow-Up Practices by Medical Oncologists in India—A Survey Report
por: Patel, Amol, et al.
Publicado: (2022)